AGY — Allergy Therapeutics Share News
0.000.00%
HealthcareSpeculativeSmall CapFalling Star
- £125.58m
- £94.12m
- £84.33m
- 59
- 31
- 22
- 27
REG - Allergy Therapeutics - Nick Wykeman to step down as CFO
AnnouncementRCS - Allergy Therapeutics - Allergy Therapeutics at H.C. Wainwright Conference
AnnouncementRCS - Allergy Therapeutics - Allergy Therapeutics shares data at WAO-BSACI
AnnouncementRCS - Allergy Therapeutics - Allergy Therapeutics at Cowen Health Conference
AnnouncementRCS - Allergy Therapeutics - Allergy Therapeutics at Investor Meet Company
AnnouncementREG - Allergy Therapeutics - Allergy Therapeutics plc – Interim Results
AnnouncementRCS - Allergy Therapeutics - Allergy Therapeutics shares positive new data
AnnouncementREG - Allergy Therapeutics - Price Monitoring Extension
AnnouncementREG - Allergy Therapeutics - Second Price Monitoring Extn
AnnouncementREG - Allergy Therapeutics - Price Monitoring Extension
AnnouncementREG - Allergy Therapeutics - Second Price Monitoring Extn
AnnouncementREG - Allergy Therapeutics - Secures new revolving credit facility
AnnouncementREG - Allergy Therapeutics - Total Voting Rights
AnnouncementREG - Allergy Therapeutics - FDA clearance of IND application for VLP Peanut
AnnouncementREG - Allergy Therapeutics - Holding(s) in Company
AnnouncementREG - Allergy Therapeutics - Half Year Trading Update & Notice of Results
AnnouncementREG - Allergy Therapeutics - Total Voting Rights
AnnouncementREG - Allergy Therapeutics - Allergy Therapeutics: Granting of Awards
AnnouncementREG - Allergy Therapeutics - Result of AGM
Announcement